; fast track product. Sec. 6. Priority review vouchers for products for prevention or treatment of endemic fungal diseases. Sec. 7. Establishment of antifungal resistance research program modeled on the CARB–X program. Sec. 8. Blockchain pilot program for hospital data security for endemic fungal disease research. 2. Continuing support for research on endemic fungal diseases The Public Health Service Act is amended by inserting after section 320A of such Act ( 42 U.S.C. 247d–8 ) the following new section: 320B. Endemic fungal diseases (a) In general The Secretary shall continue to conduct or support epidemiological, basic, translational, and clinical research related to endemic fungal diseases, including coccidioidomycosis (commonly known as and referred to in this section as Valley Fever ). (b) Reports The Secretary shall ensure that each triennial report under section 403 includes information on actions undertaken by the National Institutes of Health to carry out subsection (a) with respect to endemic fungal diseases, including Valley Fever. (c) Endemic Fungal Disease Working Group (1) Establishment The Secretary shall establish a working group, to be known as the Endemic Fungal Disease Working Group (referred to in this section as the Working Group ), comprised of representatives of appropriate Federal agencies and other non-Federal entities— (A) to provide expertise and to review all efforts within the Department of Health and Human Services related to endemic fungal disease; (B) to help ensure interagency coordination and minimize overlap with respect to such disease